Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Total 13F shares
-
51,039,620
-
Share change
-
+3,863,278
-
Total reported value
-
$2,293,785,053
-
Put/Call ratio
-
103%
-
Price per share
-
$44.95
-
Number of holders
-
164
-
Value change
-
+$169,955,348
-
Number of buys
-
115
-
Number of sells
-
48
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q4 2024
As of 31 Dec 2024,
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,039,620 shares.
The largest 10 holders included
Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Avoro Capital Advisors LLC, BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, COMMODORE CAPITAL LP, and PERCEPTIVE ADVISORS LLC.
This page lists
165
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.